Harvard Medical School, Boston, Massachusetts, USA.
Am J Phys Med Rehabil. 2010 Feb;89(2):160-72. doi: 10.1097/PHM.0b013e3181bc0bbd.
Compared with other specialties, the field of physical and rehabilitation medicine has not received the deserved recognition from clinicians and researchers in the scientific community. One of the reasons is the lack of sound evidence to support the traditional physical and rehabilitation medicine treatments. The best way to change this disadvantage is through a well conducted clinical research, such as standard placebo- or sham-controlled randomized clinical trials. Therefore, having placebo groups in clinical trials is essential to improve the level of evidence-based practice in physical and rehabilitation medicine that ultimately translates to better clinical care. To address the challenges for the use of placebo in physical and rehabilitation medicine and randomized clinical trials and to create useful recommendations, we convened a working group during the inaugural International Symposium in Placebo (February 2009, in Sao Paulo, Brazil) in which the following topics were discussed: (1) current status of randomized clinical trials in physical and rehabilitation medicine, (2) challenges for the use of placebo in physical and rehabilitation medicine, (3) bioethics, (4) use of placebo in acupuncture trials and for the treatment of low-back pain, (5) mechanisms of placebo, and (6) insights from other specialties. The current article represents the consensus report from the working group.
与其他专业相比,物理医学与康复医学领域并没有得到临床医生和科学界研究人员的应有认可。原因之一是缺乏有力的证据来支持传统的物理医学与康复医学治疗方法。改变这种劣势的最佳方法是通过精心设计的临床研究,例如标准的安慰剂或假治疗对照随机临床试验。因此,临床试验中设置安慰剂组对于提高物理医学与康复医学基于证据的实践水平至关重要,而这最终将转化为更好的临床护理。为了解决物理医学与康复医学和随机临床试验中使用安慰剂的挑战,并提出有用的建议,我们在首届国际安慰剂研讨会(2009 年 2 月,巴西圣保罗)期间召集了一个工作组,讨论了以下主题:(1)物理医学与康复医学中随机临床试验的现状,(2)物理医学与康复医学中使用安慰剂的挑战,(3)生物伦理学,(4)针灸试验和腰痛治疗中安慰剂的使用,(5)安慰剂的作用机制,以及(6)其他专业的见解。本文代表工作组的共识报告。